Top Markets
Coin of the day
Guard Therapeutics International AB (publ) Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ)

GUARD
Rang in Aktien #36113
Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company... Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard, a biological drug candidate designed to prevent kidney impairment through the protection, purification, and restoration of affected cells and tissues. Founded in 2008, the company operated as A1M Pharma AB (publ) until its renaming to Guard Therapeutics International AB (publ) in October 2019. Its headquarters are located in Stockholm, Sweden.
Aktienkurs
$0.14966934
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$3.02M
Veränderung (1 Tag)
3.72%
Veränderung (1 Jahr)
-93.70%
Land
SE
Handel Guard Therapeutics International AB (publ) (GUARD)

Kategorie

Dividendenrendite-Verlauf für Guard Therapeutics International AB (publ) (GUARD)
Dividendenrendite (TTM) von Guard Therapeutics International AB (publ) (Aktienkürzel: GUARD) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Guard Therapeutics International AB (publ) (GUARD) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber